ىاسمىن

Country: Israel

Language: Arabic

Source: Ministry of Health

Buy It Now

Active ingredient:

DROSPIRENONE 3 MG; ETHINYLESTRADIOL 0.03 MG

Available from:

BAYER ISRAEL LTD

ATC code:

G03AA12

Pharmaceutical form:

FILM COATED TABLETS

Administration route:

PER OS

Manufactured by:

BAYER PHARMA AG, GERMANY

Therapeutic group:

DROSPIRENONE AND ESTROGEN

Therapeutic indications:

Oral contraception.

Authorization date:

2011-04-01

Patient Information leaflet

                                PACKAGING TECHNOLOGY BERLIN SGQCL
Bayer AG
client: 0021,GV15
material-no.: 89280362
PZ: 2536A-4D
code-no.: 64
name: LF-BRO YASMIN TAFI 21
country: IL/MULI/BAG
colors: BLACK
version: 05.09.2022/04
Restricted Document
dimension: 103 X 38 MM
page 144 /
144
1
1986±Ε΍ΈΟΣΗΓϢΔϞΩΎͿΛϞ΍ΔϢΥϦ΃ΏΟϬϢΑΔϚϠϬΗΓϢϠϞΓΈΗϦ
ρϘϓΏϳΑρΔϔλϭΏΟϭϣΑ˯΍ϭΩϟ΍ϕ
˷
ϭγϳ
ϤͿϢΓΎͿ
ΔͿϠΡϢΙ΍ΈϏ΃
62_04.indd 144
05.09.2022 06:39:50
PACKAGING TECHNOLOGY BERLIN SGQCL
Bayer AG
client: 0021,GV15
material-no.: 89280362
PZ: 2536A-4D
code-no.: 64
name: LF-BRO YASMIN TAFI 21
country: IL/MULI/BAG
colors: BLACK
version: 05.09.2022/04
Restricted Document
dimension: 103 X 38 MM
page 143 /
143
2
ϰϠϋϲϠρϣιέϗϝϛϱϭΗΣϳ
GURVSLUHQRQHPJώϠϣ3ϥϭϧϳέϳ̡γϭέΩ
HWKLQ\OHVWUDGLROPJώϠϣ0.03ϝϭϳΩ΍έΗγ·ϝϳϧϳΛ·
ΔϳϓΎο·ΕΎϣϭϠόϣ6ΓέϘϔϟ΍ϱέυϧ΃ΔϳγΎγΣϟ΍Ε΍ΩϟϭϣϭΔϟΎόϔϟ΍έϳϏΩ΍ϭϣϟ΍
ΕέϓϭΗ΍Ϋ·˯΍ϭΩϟ΍ϥϋΓίΟϭϣΕΎϣϭϠόϣϰϠϋΓέηϧϟ΍ϩΫϫϱϭΗΣΗ˯΍ϬΩϠϞϘϞΎϢΌΗΓ΍ϜΑϏΎϬΗͿΎϬϦΚΗΣϤΌϢΗΑΓΈΗϦϞ΍Ϲ΋ΈϏ΍
ϲϟΩϳλϟ΍ϭ΃ΏϳΑρϟ΍ϲόΟ΍έˬΔϳϓΎο·ΔϠ΋γ΃ϙϳΩϟ
ϙΗϟΎΣϟΔϬΑΎηϣΔϳΑρϟ΍ϡϬΗϟΎΣϥ΃ϙϟ΍ΩΑϭϟϭϰΗΣϡϫέοϳΩϗϭϬϓϥϳέΧ϶ϟϪρόΗϻϙϠΟ΃ϥϣ˯΍ϭΩϟ΍΍Ϋϫϑλϭ
ΩόΑϥϬϳΩϟΔϳέϬηϟ΍ΓέϭΩϟ΍έϬυΗϡϟϲΗ΍ϭϠϟ΍ΕΎϘϫ΍έϣϟ΍ϭ΃˯ΎγϧϠϟιλΧϣέϳϏϥϳϣγΎϳ
62_04.indd 143
05.09.2022 06:39:50
PACKAGING TECHNOLOGY BERLIN SGQCL
Bayer AG
client: 0021,GV15
material-no.: 89280362
PZ: 2536A-4D
code-no.: 64
name: LF-BRO YASMIN TAFI 21
country: IL/MULI/BAG
colors: BLACK
version: 05.09.2022/04
Restricted Document
dimension: 103 X 38 MM
page 142 /
142
3
˯΍ϬΩϞ΍ϤΫϬΔΑϚΈϢϞ΍ΔͿϦϬϢΈϬϬϞ΍ϜϢΣϞ΍ΪϦϢϜ΋ΎΓϬϤΫΔϢΎϪΕΎϢϬϠΌϢ
•
ϊϧϣϟΔϧΎϣ΃
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet English 15-11-2022
Public Assessment Report Public Assessment Report English 17-11-2019
Patient Information leaflet Patient Information leaflet Hebrew 01-01-2024

View documents history